Skip to content

Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF)

Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04090840
Acronym
LIFE AS IF
Enrollment
51
Registered
2019-09-16
Start date
2019-08-01
Completion date
2021-01-30
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Diabetes Mellitus, Type 2, Morbid Obesity, Obesity

Keywords

obesity, fasting, diet

Brief summary

BACKGROUND AND RATIONALE Two out of three Americans are overweight and obesity is associated with hypertension, sleep apnea, atrial fibrillation. Metabolic syndrome with centripetal obesity is also a precursor to insulin resistance and the development of Type II diabetes mellitus. While multiple strategies for weight reduction are often recommended in physician visits, calculating calories and energy expenditure is often inconvenient and does not promote compliance. Intermittent fasting, or time-restricted eating, is a methods to limit caloric intake by fasting for 16 hours to promote ketosis and suppress insulin secretion. Weight loss and reduction in body fat has been observed with brief periods of intervention as time-restricted eating results in reduction in overall caloric intake. Prospective feasibility studies and randomized comparative trials with intermittent fasting are lacking. The investigators recommend caloric restriction in all of our patients that suffer from arrhythmias and BMI \>30. However, they have not systematically measured compliance and the efficacy of lifestyle interventions. Lifestyle counseling and weight loss has been shown to decrease the progression and burden of symptomatic atrial fibrillation. Intermittent fasting can result in consistent reductions in body fat and weight without specific lifestyle counseling. The aim of the present observation cohort study is to assess the feasibility of recommending intermittent fasting in an arrhythmia clinic with regard to compliance and efficacy. The investigators hypothesize that compliance and adherence to a 16/8 intermittent fasting regimen will be \>25% and result in weight loss, compared to the 6 month trend prior to the intervention. This pilot study will serve as the basis to power the first randomized trial comparing intermittent fasting with other types of dietary counseling for arrhythmia outcomes. OBJECTIVES To prospectively assess compliance to prescribed intermittent fasting, measured by adherence and change in weight at 6 months.

Interventions

BEHAVIORALIntermittent Fasting

Time restricted eating for 8 hours per day, with 16 hour fast. During the daily fast, patients are encouraged to drink water, black coffee, or green tea without sugar, cream, milk, or sweeteners.

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective observation study of lifestyle intervention with intermittent fasting (time-restricted eating) of 16 hours every day.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 * BMI≥ 30 * Ongoing evaluation and management of cardiac arrhythmias

Exclusion criteria

* Pregnant or nursing * Eating disorder or history of eating disorders (self-report) * Diabetic mellitus type 1 or insulin requiring type 2 diabetes

Design outcomes

Primary

MeasureTime frameDescription
Weight loss6 monthsPatients will be weighed weekly for the first month and than have weight checks in clinic monthly

Secondary

MeasureTime frameDescription
Body Mass IndexMonthly until 6 monthscalculated from height and weight measured in clinic
Waist CircumferenceMonthly until 6 monthsmeasured by research specialist at umbilicus
Blood PressureMonthly until 6 monthsmeasured in clinic by nursing staff
Quality of Life Assessment6 monthsSF36 Questionnaire to be filled out by patient
Hemoglobin a1c6 monthsBlood test in patients with diabetes mellitus

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026